Does Dose Track track Rybelsus as a tablet, not a shot?

Yes. Rybelsus is semaglutide in tablet form. You track it as a daily oral medication counted by tablets in a bottle, with no injection site.

Can I see my HbA1c next to my Rybelsus doses?

Yes. Upload a lab report as a photo or PDF, check the values the app reads out, and they are added to your timeline next to your doses. You can set your own HbA1c target range.

Can I switch from Rybelsus to Ozempic in Dose Track?

Yes. Add the new medication with its own schedule and stop the old one; your Rybelsus history stays in the log. Switching is a prescriber decision; the label section on switching is summarized on our Rybelsus dosing page.

Rybelsus Tracker: Daily Dose & Refills

Dose Track reminds you to take Rybelsus each morning, logs each tablet, and counts the 30 in every bottle so a refill never comes late. Your HbA1c results sit next to your doses, and each step from 3 mg to 7 mg or 14 mg is kept in the log.

What is the Rybelsus schedule?

Per the FDA label (2.2), Rybelsus starts at 3 mg once daily for days 1–30, a dose the label says is not effective for glycemic control, then 7 mg once daily for days 31–60. From day 61, the label's schedule either stays at 7 mg or increases to 14 mg if additional glycemic control is needed.

From the FDA label for Rybelsus, section 2.2.
When	Dose on the label	Label note
Days 1–30	3 mg once daily	Starting (initiation) dosage; the label says it is not effective for glycemic control
Days 31–60	7 mg once daily	Escalation dosage
Day 61 onward	7 mg once daily, or 14 mg once daily	Stays at 7 mg if no additional glycemic control is needed; 14 mg if additional glycemic control is needed

Set Rybelsus as a daily medication with a morning reminder. The 3 mg starting dose lasts 30 days; record 7 mg from the day you start it, and 14 mg if your prescriber moves you up later.

What form does Rybelsus come in?

Rybelsus is a tablet in bottles of 30, one strength per bottle. The label notes that 3 mg is a starting dose only, not a dose for blood sugar control, which is one reason to keep the date of each step.

From the FDA label for Rybelsus, sections 3; 16.
Product	Tablet strength	Pack	Description
Rybelsus	3 mg	Bottle of 30 tablets	White to light yellow, oval, debossed "3" on one side and "novo" on the other
Rybelsus	7 mg	Bottle of 30 tablets	White to light yellow, oval, debossed "7" on one side and "novo" on the other
Rybelsus	14 mg	Bottle of 30 tablets	White to light yellow, oval, debossed "14" on one side and "novo" on the other
Ozempic tablets	1.5 mg	Bottle of 30 tablets	White to light yellow, round, debossed "1.5" on one side and "novo" on the other
Ozempic tablets	4 mg	Bottle of 30 tablets	White to light yellow, round, debossed "4" on one side and "novo" on the other
Ozempic tablets	9 mg	Bottle of 30 tablets	White to light yellow, round, debossed "9" on one side and "novo" on the other

What should you track on Rybelsus?

Each row is something worth writing down for Rybelsus, why it matters for this medicine, and what Dose Track does with it.

What to track on Rybelsus and how Dose Track handles it.
What to track	Why it matters	In Dose Track
Morning dose	The label gives one tablet once daily on an empty stomach with up to 4 ounces of plain water, then at least 30 minutes before food, drink or other tablets.	A daily reminder at your time; one tap to log.
Dose step	3 mg for 30 days, then 7 mg; 14 mg after at least 30 days on 7 mg if more control is needed (2.2).	Record each new strength from the day it starts. The log shows days on each strength.
Tablets left	Bottles of 30 tablets (3, 16).	Each logged tablet comes off the bottle; run-out and order-by dates follow.
HbA1c and glucose	Rybelsus is labeled to improve blood sugar control in adults with type 2 diabetes.	Upload labs as a photo or PDF; HbA1c and glucose are read out and charted next to your doses.
Side effects	Nausea, abdominal pain, diarrhea and decreased appetite were the most common reactions (6.1).	Quick picks for GLP-1 side effects with a severity, shown against the strength you were on.

Which side effects does the Rybelsus label list?

Adverse reactions reported in ≥5% of semaglutide tablet-treated patients and more often than placebo, pool of 2 placebo-controlled trials in type 2 diabetes (label Table 2; trials used Rybelsus strengths). Section 6.1, Table 2.
Reaction	Placebo (N=362)	Semaglutide tablets 7 mg (N=356)	Semaglutide tablets 14 mg (N=356)
Nausea	6%	11%	20%
Abdominal pain	4%	10%	11%
Diarrhea	4%	9%	10%
Decreased appetite	1%	6%	9%
Vomiting	3%	6%	8%
Constipation	2%	6%	5%

Per the label, the majority of reports of nausea, vomiting and/or diarrhea occurred during dose escalation. Gastrointestinal adverse reactions overall occurred in 21% (placebo), 32% (7 mg), and 41% (14 mg), and led to discontinuation in 1%, 4%, and 8%, respectively (6.1).

Dose Track has quick picks for the side effects people on GLP-1 medicines log most: nausea, constipation, diarrhea, reflux or heartburn, tiredness, low appetite and headache. You can type in anything else, set how bad it was, and see it next to the dose step you were on.

Rybelsus side effects from the FDA label

What if you miss a Rybelsus dose?

Per the label, a missed dose is skipped and the next dose is taken the following day. The label also says not to take more than one tablet per day. (2.1) Missed a Rybelsus dose.

A morning that was not logged shows as missed for that day, so gaps are easy to count.

More about Rybelsus on Dose Track

Dose Track is a tracking app, not medical advice. It records what you and your prescriber decide; it does not recommend doses. Check any dose change with your prescriber.

Rybelsus tracker: daily tablets, steps and HbA1c